chr3-94036663-C-T
Position:
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_001174150.2(ARL13B):c.598C>T(p.Arg200Cys) variant causes a missense change. The variant allele was found at a frequency of 0.00000205 in 1,461,824 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000021 ( 0 hom. )
Consequence
ARL13B
NM_001174150.2 missense
NM_001174150.2 missense
Scores
9
9
1
Clinical Significance
Conservation
PhyloP100: 4.52
Genes affected
ARL13B (HGNC:25419): (ADP ribosylation factor like GTPase 13B) This gene encodes a member of the ADP-ribosylation factor-like family. The encoded protein is a small GTPase that contains both N-terminal and C-terminal guanine nucleotide-binding motifs. This protein is localized in the cilia and plays a role in cilia formation and in maintenance of cilia. Mutations in this gene are the cause of Joubert syndrome 8. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Mar 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 14 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.956
PP5
Variant 3-94036663-C-T is Pathogenic according to our data. Variant chr3-94036663-C-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 1993.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-94036663-C-T is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARL13B | NM_001174150.2 | c.598C>T | p.Arg200Cys | missense_variant | 5/10 | ENST00000394222.8 | NP_001167621.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARL13B | ENST00000394222.8 | c.598C>T | p.Arg200Cys | missense_variant | 5/10 | 1 | NM_001174150.2 | ENSP00000377769.3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1461824Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 727210
GnomAD4 exome
AF:
AC:
3
AN:
1461824
Hom.:
Cov.:
31
AF XY:
AC XY:
1
AN XY:
727210
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
Bravo
AF:
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Joubert syndrome 8 Pathogenic:3
Pathogenic, no assertion criteria provided | literature only | OMIM | Aug 01, 2008 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | May 31, 2024 | - - |
Pathogenic, criteria provided, single submitter | research | UW Hindbrain Malformation Research Program, University of Washington | Feb 23, 2015 | - - |
Joubert syndrome and related disorders Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Aug 29, 2023 | Variant summary: ARL13B c.598C>T (p.Arg200Cys) results in a non-conservative amino acid change located in the C-terminal coiled-coiled domain (Higginbotham_2012) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 251344 control chromosomes (gnomAD). c.598C>T has been reported in the literature in at least one compound heterozygous individual affected with Joubert Syndrome (e.g., Cantagrel_2008, Bachmann-Gagescu_2015). These data suggest the variant may be associated with disease. Several publications report experimental evidence evaluating an impact on protein function, finding that the variant is unable to rescue a curved tail and absence of cystic kidney phenotype in a zebrafish model (rescue is reduced 76-85% relative to wild-type; e.g., Cantagrel_2008). Moreover, other studies found the variant displayed moderately severe defects in interneuron migration (e.g., Higginbotham_2012) and in mediating INPP5E ciliary targeting (e.g., Humbert_2012, Fujisawa_2021). The following publications have been ascertained in the context of this evaluation (PMID: 26092869, 18674751, 34447983, 23153492, 23150559, 27153923). One submitter has reported clinical-significance assessments for this variant to ClinVar after 2014 and has classified the variant as pathogenic/likely pathogenic. Additionally, a different missense variant affecting the same codon, c.599G>A (p.Arg200His), has been reported in several individuals affected with Joubert syndrome (PMIDs: 27894351, 27457812, 34645488) and is classified as pathogenic/likely pathogenic in ClinVar. Based on the evidence outlined above, the variant was classified as likely pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Uncertain
.;.;D;D
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;.;D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D;D;D
MetaSVM
Uncertain
D
MutationAssessor
Uncertain
.;.;M;M
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;D;D;D
REVEL
Pathogenic
Sift
Pathogenic
D;D;D;D
Sift4G
Pathogenic
D;D;D;D
Polyphen
1.0
.;D;D;D
Vest4
MutPred
0.76
.;.;Gain of loop (P = 0.0166);Gain of loop (P = 0.0166);
MVP
MPC
0.50
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at